OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ALGO.NLB56

Light AI Inc

Advanced Medical Equipment & TechnologyVerified

Light AI Inc operates with a highly liquid balance sheet, as evidenced by a current ratio of 8.67, indicating strong short-term liquidity. The company is entirely equity-funded, with no long-term debt and a debt-to-equity ratio of 0.0, which suggests a conservative capital structure. However, the company is currently unprofitable, with a net loss of CAD 346,300 and operating losses of CAD 376,870 in the latest reporting period. Return on equity and return on assets are negative at -65.22% and -57.69%, respectively, indicating poor capital efficiency and asset utilization. The company's profitability metrics fall significantly below the industry median for Advanced Medical Equipment & Technology, where positive returns and operating margins are typically expected. The negative returns suggest that the company is not generating value for shareholders and is likely in a high R&D or market expansion phase. The operating cash flow of -CAD 873,110 further underscores the company's reliance on external financing or asset sales to fund operations. Light AI Inc's revenue concentration is not disclosed in the available data, but the absence of segment or geographic breakdowns implies a lack of diversification in its business model. This could pose a risk if the company's primary market or product line experiences a downturn. The company's exposure to a single geographic or product market is a potential vulnerability that is not currently quantified in the available data. The company's growth trajectory is not yet defined, as there is no historical revenue data provided to assess growth rates. The outlook for the current fiscal year is not quantified, but the company's current financial position suggests a focus on long-term development rather than near-term revenue growth. The absence of a clear growth narrative or revenue history makes it difficult to project future performance. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. However, the company's negative operating cash flow and net losses suggest a potential need for future financing, which could lead to dilution if not managed through asset sales or debt. The dilution potential is currently low, but the company's financial position could change rapidly if operating performance does not improve. Recent events, including filings and transcripts, are not disclosed in the available data, which limits the ability to assess the company's strategic direction or management commentary. The absence of recent disclosures may indicate a lack of public market activity or a focus on private development. Investors should monitor future filings for insights into the company's operational and financial strategy.

30-day price · ALGO.NLB+0.10 (+123.5%)
Low$0.09High$0.20Close$0.19As of16 May, 00:00 UTC
Profile
CompanyLight AI Inc
TickerALGO.NLB
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. Light AI Inc develops and commercializes advanced medical equipment and technology, focusing on healthcare equipment solutions.

Classification. Light AI Inc is classified under the Healthcare economic sector, Healthcare Services & Equipment business sector, and Advanced Medical Equipment & Technology industry with 92% confidence.

Light AI Inc operates with a highly liquid balance sheet, as evidenced by a current ratio of 8.67, indicating strong short-term liquidity. The company is entirely equity-funded, with no long-term debt and a debt-to-equity ratio of 0.0, which suggests a conservative capital structure. However, the company is currently unprofitable, with a net loss of CAD 346,300 and operating losses of CAD 376,870 in the latest reporting period. Return on equity and return on assets are negative at -65.22% and -57.69%, respectively, indicating poor capital efficiency and asset utilization. The company's profitability metrics fall significantly below the industry median for Advanced Medical Equipment & Technology, where positive returns and operating margins are typically expected. The negative returns suggest that the company is not generating value for shareholders and is likely in a high R&D or market expansion phase. The operating cash flow of -CAD 873,110 further underscores the company's reliance on external financing or asset sales to fund operations. Light AI Inc's revenue concentration is not disclosed in the available data, but the absence of segment or geographic breakdowns implies a lack of diversification in its business model. This could pose a risk if the company's primary market or product line experiences a downturn. The company's exposure to a single geographic or product market is a potential vulnerability that is not currently quantified in the available data. The company's growth trajectory is not yet defined, as there is no historical revenue data provided to assess growth rates. The outlook for the current fiscal year is not quantified, but the company's current financial position suggests a focus on long-term development rather than near-term revenue growth. The absence of a clear growth narrative or revenue history makes it difficult to project future performance. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. However, the company's negative operating cash flow and net losses suggest a potential need for future financing, which could lead to dilution if not managed through asset sales or debt. The dilution potential is currently low, but the company's financial position could change rapidly if operating performance does not improve. Recent events, including filings and transcripts, are not disclosed in the available data, which limits the ability to assess the company's strategic direction or management commentary. The absence of recent disclosures may indicate a lack of public market activity or a focus on private development. Investors should monitor future filings for insights into the company's operational and financial strategy.
Key takeaways
  • Light AI Inc is currently unprofitable with negative returns on equity and assets.
  • The company has a highly liquid balance sheet but is entirely equity-funded with no long-term debt.
  • The absence of segment or geographic revenue data suggests a lack of diversification.
  • The company's growth trajectory is undefined due to the lack of historical revenue data.
  • Low liquidity and dilution risk are reported, but the company's negative cash flow could necessitate future financing.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCAD
Revenue
Gross profit
Operating income-$376.9k
Net income-$346.3k
R&D
SG&A
D&A
SBC
Operating cash flow-$873.1k
CapEx
Free cash flow
Total assets$600.3k
Total liabilities$69.3k
Total equity$531.0k
Cash & equivalents
Long-term debt$0.00
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4-$348.5k-$188.6k-$118.2k
FY-3-$181.3k$67.1k$34.4k
FY-2-$208.3k-$68.9k
FY-1-$13.6M-$13.1M-$13.1M
FY0-$16.3M-$16.1M-$16.1M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$945.1k$637.0k
FY-3$884.0k$704.1k
FY-2$692.1k$635.3k
FY-1$17.1M$14.6M
FY0$6.9M$5.5M
PeriodOCFCapExFCFSBC
FY-4-$337.1k-$118.2k
FY-3-$25.1k$34.4k
FY-2-$161.0k
FY-1-$6.8M-$13.1M
FY0-$11.1M-$18.4k-$16.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7-$376.9k-$346.3k
FQ-6-$215.9k-$215.9k
FQ-5-$280.9k-$280.9k
FQ-4-$13.1M
FQ-3-$4.3M-$4.3M-$4.3M
FQ-2-$4.1M-$4.0M-$4.0M
FQ-1-$5.6M-$5.6M-$5.6M
FQ0-$2.3M-$2.3M-$2.3M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$600.3k$531.0k
FQ-6$440.4k$315.1k
FQ-5$353.3k-$350.2k$9.3k
FQ-4$17.1M$14.6M
FQ-3$15.0M$12.6M
FQ-2$10.8M$8.9M
FQ-1$8.5M$6.8M
FQ0$6.9M$5.5M
PeriodOCFCapExFCFSBC
FQ-7-$873.1k
FQ-6-$915.1k
FQ-5-$106.4k
FQ-4-$6.8M-$13.1M
FQ-3-$5.2M-$4.3M
FQ-2-$7.8M-$4.8k-$4.0M
FQ-1-$9.7M-$6.0k-$5.6M
FQ0-$11.1M-$18.4k-$2.3M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$531.0k
Net cash
Current ratio8.7
Debt/Equity0.0
ROA-57.7%
ROE-65.2%
Cash conversion2.5%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Equipment · cohort 91 companies
MetricALGO.NLBActivity
Op margin-16.5% medp25 -174.5% · p75 8.8%
Net margin-16.5% medp25 -172.4% · p75 8.4%
Gross margin47.4% medp25 34.2% · p75 65.3%
CapEx / revenue-5.4% medp25 -12.5% · p75 -2.2%
Debt / equity0.0%4.3% medp25 0.0% · p75 28.0%bottom quartile
Recent coverage
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 00:14 UTC#138f4273
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 07:52 UTCJob: 89d69053